Whitegate Investment Counselors’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-594,284
Closed -$4.1M 212
2020
Q3
$4.1M Hold
594,284
0.75% 39
2020
Q2
$3.88M Hold
594,284
0.77% 38
2020
Q1
$3.93M Hold
594,284
0.95% 36
2019
Q4
$6.16M Hold
594,284
1.12% 26
2019
Q3
$3.76M Hold
594,284
0.74% 46
2019
Q2
$4.42M Hold
594,284
0.89% 37
2019
Q1
$3.65M Hold
594,284
0.76% 48
2018
Q4
$6.85M Sell
594,284
-7,559
-1% -$129K 1.58% 16
2018
Q3
$13M Sell
601,843
-12,441
-2% -$235K 2.66% 4
2018
Q2
$9.69M Hold
614,284
1.98% 10
2018
Q1
$11.6M Sell
614,284
-40,000
-6% -$789K 2.47% 5
2017
Q4
$11.4M Hold
654,284
2.38% 7
2017
Q3
$9.79M Hold
654,284
2.16% 8
2017
Q2
$12.1M Buy
+654,284
New +$11.4M 2.74% 4

Other funds holding ARA

Whitegate Investment Counselors's ARA Position: Q4 2020 in Review

Whitegate Investment Counselors sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2020, closing a stake of 594,284 shares — an estimated $4.1M sold.

Whitegate Investment Counselors first reported a position in ARA in Q2 2017 and held it in 14 quarters. The position peaked at $13M in Q3 2018. 67 funds tracked by Wall St. Rank hold ARA as of Q4 2020.

  • Whitegate Investment Counselors reported no remaining American Renal Associates Holdings, Inc position as of Q4 2020 after selling out during the quarter.
  • Whitegate Investment Counselors sold 594,284 American Renal Associates Holdings, Inc shares in Q4 2020, an estimated $4.1M.
  • Whitegate Investment Counselors first reported a position in American Renal Associates Holdings, Inc in Q2 2017 and held it in 14 quarters.
  • Whitegate Investment Counselors's American Renal Associates Holdings, Inc position peaked at $13M in Q3 2018.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2020.

Based on Whitegate Investment Counselors's 13F filing for Q4 2020, filed 25 Jan 2021.